moderna covid vaccine

Order byBest matchMost fresh

FDA Will Approve COVID-19 Vaccine

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

· 18h · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

STAT · 1h

FDA asks mRNA vaccine makers to widen age range for rare heart risk warning

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

Citing low uptake of recent Covid shots, “the American people, along with many health care providers, remain unconvinced” that the shots are needed, the officials said.

· 5h

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Moderna Pulls Promising Covid-Flu Combo Shot as RFK Continues Antivax Campaign

Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the drugmaker said it would withdraw its application seeking approval from the U.S.

1don MSN

Moderna pulls application for COVID-flu combination shot

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot,

49mon MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into

MPR5h

Moderna Withdraws BLA for Flu/COVID-19 Combo Vaccine Candidate

Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after

BioPharma Dive1d

Moderna pulls application for combo COVID, flu shot

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from yesterday.

STAT1d

Pharmalittle: We’re reading about Trump’s drug-pricing plan, a Moderna change of plans, and more

The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.

AARP2d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.